Singular Genomics Systems, Inc. 10-K Item 1C cybersecurity disclosure for fiscal year ended December 31, 2023. The Company describes its cybersecurity risk management program (CIS Controls framework, Audit Committee oversight, management responsibilities of CFO, Head of IT and General Counsel) but states it has not identified risks from known cybersecurity threats, including prior incidents, that have materially affected or are reasonably likely to materially affect the Company. No specific cybersecurity incident is disclosed.